Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by elgin1on Nov 05, 2019 2:51pm

86 Views

Post# 30311833

Presentation with data showing Insulin production

https://www.sernova.com/pdf/updates/Sernova%20Corp%20Presentation%20November%202019.pdf

Look at page 20,21, 22 Bioteck

Insulin is produced .... from C peptide. H1ac confirms it. More detailed data will be released in December.

Everyone should do their own due diligence. I am just waiting for data from the second patient for this to be more derisked.

Elgin

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features